A compound called calcein may act to inhibit topoisomerase IIβ-binding protein 1 (TopBP1), which enhances the growth of tumors, said researchers from Baylor College of Medicine in a report that appears online in the journal ...
Nov 17, 2014
5 / 5 (4) | 0
In a step forward in the battle against cancer, researchers have identified promising compounds to inhibit a key driver of many forms of the disease, including lung, prostate, colon, bladder and pancreatic cancer.
Nov 21, 2014
4.3 / 5 (3) | 0